Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media

Journal of Clinical Microbiology

Volumn 37, Issue 10, 1999, Pages 3179-3186

  Pfyffer, Gaby E ^a   Bonato, Donald A ^b   Ebrahimzadeh, Adeleh ^c   Gross, Wendy ^b   Hotaling, Jacqueline ^d   Kornblum, John ^c   Laszlo, Adalbert ^e   Roberts, Glenn ^f   Salfinger, Max ^d   Wittwer, Franziska ^a   Siddiqi, Salman ^g  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d WADSWORTH CENTER   (United States)

^e LAB CENTRE FOR DISEASE CONTROL   (Canada)

^f MAYO CLINIC   (United States)

^g BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHIONAMIDE; KANAMYCIN; OFLOXACIN; RIFABUTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CULTURE MEDIUM; LABORATORY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RADIOMETRY; REPRODUCIBILITY;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0032848641     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.10.3179-3186.1999     Document Type: Article

References (38)

1. Allen, B. W., D. A. Michison, Y. C. Chan, W. W. Yew, and W. G. L. Allan. 1983. Amikacin in the treatment of pulmonary tuberculosis. Tubercle 64: 111-118.
2. Benjamin, W. H., Jr., K. B. Waites, A. Beverly, L. Gibbs, M. Waller, S. Nix, S. A. Moser, and M. Willert. 1998. Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens. J. Clin. Microbiol. 36:3234-3238.
3. Bergman, J. S., and G. L. Woods. 1998. Evaluation of the ESP Culture System II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs. J. Clin. Microbiol. 36:2940-2943.
4. Casal, M., F. Rodriguez, J. Gutierrez, P. Ruiz, and R. Villalba. 1988. In vitro activity of antimicrobial agents against mycobacteria. Drugs Exp. Clin. Res. 14:741-745.
5. Chen, C. C., J. Shin, P. Lindholm-Levy, and L. B. Heifets. 1989. Minimal inhibitory concentrations of rifabutin, ciprofloxacin, ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan. Am. Rev. Respir. Dis. 140:987-989.
6. Della Bruna, C., and P. Olliaro. 1994. Setting breakpoints for assessing the sensitivity of mycobacteria to rifabutin in vitro. J. Antimicrob. Chemother. 34:184-186.
7. Dhillon, J., and D. A. Mitchison. 1992. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages. Am. Rev. Respir. Dis. 145:212-214.
8. Fenlon, C. H., and M. H. Cynamon. 1986. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob. Agents Chemother. 29:386-388.
9. Gay, J. D., D. R. DeYoung, and G. D. Roberts. 1984. In vitro activities of norfloxacin and ciprofloxacin against M. tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. Antimicrob. Agents Chemother. 26:94-96.
10. Griffith, M. E., and H. L. Bodily. 1992. Stability of antimicrobial drugs in susceptibility testing. Antimicrob. Agents Chemother. 36:2398-2402.
11. Gross, W. M., and J. E. Hawkins. 1986. Radiometrie susceptibility testing of Mycobacterium tuberculosis with secondary drugs, abstr. C-378, p. 391. In Abstracts of the 86th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
12. Hanna, B. A., A. Ebrahimzadeh, L. B. Elliott, M. A. Morgan, S. M. Novak, S. Rüsch-Gerdes, M. Acio, D. F. Dunbar, T. M. Holmes, C. H. Rexer, C. Savthyakumar, and A. M. Vannier. 1999. Multicenter evaluation of the BACTEC 960 System for recovery of mycobacteria. J. Clin. Microbiol. 37: 782-784.
13. Heifets, L., and P, Lindholm-Levy. 1989. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrob. Agents Chemother. 33: 1298-1301.
14. Heifets, L. B. 1991. Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, Fla.
15. Heifets, L. B., and P. J. Lindholm-Levy. 1987. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle 68:267-276.
16. Heifets, L. B., P. Lindholm-Levy, and M. Flory. 1991. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 143:268-278.
17. Heifets, L. B., P. Lindholm-Levy, and M. A. Flory. 1996. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 141:626-630.
18. Inderlied, C. B., and K. A. Nash. 1996. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids, p. 127-175. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, Md.
19. Kennedy, N., R. Fox, G. M. Kisyombe, A. O. S. Satrium, L. O. Uiso, A. R. C. Ramsy, F. I. Nigowi, and S. H. Gillespie. 1993. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am. Rev. Respir. Dis. 148:1547-1551.
20. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology. A guide for the level III laboratory. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Ga.
21. LaBombardi, V. J., and L. Cataldo-Caputzal. 1993. Ciprofloxacin susceptibility testing by MIC and disc elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob. Agents Chemother. 37:1556-1557.
22. Lee, C., and L. B. Heifets. 1987. Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods. Am. Rev. Respir. Dis. 136:349-352.
23. Pfyffer, G. E., H.-M. Welscher, P. Kissling, C. Cieslak, M. J. Casal, J. Gutierrez, and S. Rüsch-Gerdes. 1997. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J. Clin. Microbiol. 35:364-368.
24. Rastogi, N. 1993. Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy, p. 245-300. In D. Raoult (ed.), Antimicrobial agents and intracellular pathogens. CRC Press, Boca Raton, Fla.
25. Rastogi, N., V. Labrousse, and K. S. Goh. 1996. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr. Microbiol. 33:167-175.
26. Reddy, V. M., G. Nadadhur, D. Daneluzzi, J. F. O'Sullivan, and P. R. Gangadharam. 1996. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Antimicrob. Agents Chemother. 40:633-636.
27. Roberts, G. D., N. L. Goodman, L. Heifets, H. W. Larsch, T. H. Lindner, J. K. McClatchy, M. R. McGinnis, S. H. Siddiqi, and P. Wright. 1983. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J. Clin. Microbiol. 18:689-696.
28. Ruiz-Serrano, M. J., M. S. Diaz, L. Martinez-Sanchez, J. Albadalejo, A. Ortega, and E. Bouza. 1998. Evaluation of the MB/BacT for susceptibility testing of Mycobacterium tuberculosis, abstr. D-101, p. 157. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
29. Rüsch-Gerdes, S., C. Domehl, G. Nardi, M. R. Gismondo, H.-M. Welscher, and G. E. Pfyffer. 1999. Multicenter evaluation of the Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J. Clin. Microbiol. 37:45-48.
30. Salfinger, M., L. B. Reller, B. Demchuk, and Z. T. Johnson. 1989. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res. Microbiol. 140:301-309.
31. Siddiqi, S. H. 1995. BACTEC 460 TB System. Product and procedure manual, revision D. Becton Dickinson Microbiology Systems, Sparks, Md.
32. Siddiqi, S. H., J. P. Libonati, and G. Middlebrook. 1981. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 13:908-912.
33. Siddiqi, S. H., J. E. Hawkins, and A. Laszlo. 1985. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by radiometric and two conventional methods. J. Clin. Microbiol. 22:919-923.
34. Tenover, F. C., J. K. Crawford, R. E. Huebner, L. H. Geiter, R. Horsburgh, Jr., and R. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770.
35. Tortoli, E., P. Cichero, M. G. Chirillo, M. R. Gismondo, L. Bono, G. Gesu, M. T. Simonetti, G. Volpe, G. Nardi, and P. Marone. 1998. Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood. J. Clin. Microbiol. 36:1378-1381.
36. Walters, S. B., and B. A. Hanna. 1996. Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by the Mycobacteria Growth Indicator Tube method. J. Clin. Microbiol. 34:1565-1567.
37. World Health Organization. 1998. Report on the global tuberculosis epidemic. World Health Organization, Geneva, Switzerland.
38. World Health Organization. 1997. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994-1997. World Health Organization, Geneva, Switzerland.